Literature DB >> 35072830

Temporal trends in the prevalence and characteristics of hypouricaemia: a descriptive study of medical check-up and administrative claims data.

Ruriko Koto1,2, Izumi Sato1,3, Masanari Kuwabara4, Tomotsugu Seki1,5, Koji Kawakami6.   

Abstract

We aimed to describe temporal trends in the prevalence and characteristics of hypouricaemia. We analysed medical check-up and administrative claims data to calculate hypouricaemia prevalence from 2009 to 2019. Then, using data from 2018 to 2019, we compared the characteristics of individuals with and without hypouricaemia. We also compared the characteristics of those with lower (serum uric acid [sUA] ≤ 1.0 mg/dL) and higher (1.0 mg/dL < sUA ≤ 2.0 mg/dL) hypouricaemia. In total, 1,600,290 subjects underwent medical check-ups. The age-adjusted prevalence of hypouricaemia remained stable at 0.2% overall (men, 0.1%; women, 0.4%). We identified 1704 subjects with hypouricaemia (598 men and 1106 women) among 796,508 subjects and studied their characteristics. The proportion of most pre-existing diseases, including urinary stones, was lower in those with hypouricaemia than in those without hypouricaemia. Cardio-metabolic diseases and Parkinson's disease were more frequent in men with hypouricaemia than those without hypouricaemia. Women with hypouricaemia tended to have healthier characteristics. Hypertension and dyslipidaemia were more common in the lower hypouricaemia group than in the higher hypouricaemia group. The age-adjusted prevalence of hypouricaemia remained stable over 10 years. The characteristics of hypouricaemia subjects appear to differ between the sexes and between lower and higher hypouricaemia groups. Key Points • The prevalence of hypouricaemia remained almost unchanged over 10 years. • Cardio-metabolic diseases and Parkinson's disease were more frequent in men with hypouricaemia than in those without hypouricaemia. • Subjects with extremely low serum urate (sUA ≤ 1.0 mg/dL) appeared to have higher cardio-metabolic disease risks. • Routine checks of sUA could be useful in screening or predicting these conditions.
© 2022. International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Epidemiology; Hypouricaemia; Prevalence; Uric acid

Mesh:

Substances:

Year:  2022        PMID: 35072830     DOI: 10.1007/s10067-022-06071-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

Review 1.  Hypouricemia and tubular transport of uric acid.

Authors:  N Esparza Martín; V García Nieto
Journal:  Nefrologia       Date:  2011       Impact factor: 2.033

2.  Depletion of Uric Acid Due to SLC22A12 (URAT1) Loss-of-Function Mutation Causes Endothelial Dysfunction in Hypouricemia.

Authors:  Shinobu Sugihara; Ichiro Hisatome; Masanari Kuwabara; Koichiro Niwa; Nani Maharani; Masahiko Kato; Kazuhide Ogino; Toshihiro Hamada; Haruaki Ninomiya; Yukihito Higashi; Kimiyoshi Ichida; Kazuhiro Yamamoto
Journal:  Circ J       Date:  2015-02-23       Impact factor: 2.993

3.  Association between hypouricemia and reduced kidney function: a cross-sectional population-based study in Japan.

Authors:  Minako Wakasugi; Junichiro James Kazama; Ichiei Narita; Tsuneo Konta; Shouichi Fujimoto; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Koichi Asahi; Kenjiro Kimura; Masahide Kondo; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Am J Nephrol       Date:  2015-03-18       Impact factor: 3.754

Review 4.  Hypouricemia: what the practicing rheumatologist should know about this condition.

Authors:  Carlos Pineda; Carina Soto-Fajardo; Jaime Mendoza; Jessica Gutiérrez; Hugo Sandoval
Journal:  Clin Rheumatol       Date:  2019-10-24       Impact factor: 2.980

5.  Prevalence and complications of hypouricemia in a general population: A large-scale cross-sectional study in Japan.

Authors:  Masanari Kuwabara; Koichiro Niwa; Akira Ohtahara; Toshihiro Hamada; Satoshi Miyazaki; Einosuke Mizuta; Kazuhide Ogino; Ichiro Hisatome
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

Review 6.  Clinical practice guideline for renal hypouricemia (1st edition).

Authors:  Akiyoshi Nakayama; Hirotaka Matsuo; Akira Ohtahara; Kazuhide Ogino; Masayuki Hakoda; Toshihiro Hamada; Makoto Hosoyamada; Satoshi Yamaguchi; Ichiro Hisatome; Kimiyoshi Ichida; Nariyoshi Shinomiya
Journal:  Hum Cell       Date:  2019-02-19       Impact factor: 4.174

7.  Prevalence and possible causes of hypouricemia at a tertiary care hospital.

Authors:  Chang-Nam Son; Ji-Min Kim; Sang-Hyon Kim; Soo-Kyung Cho; Chan-Bum Choi; Yoon-Kyoung Sung; Tae-Hwan Kim; Sang-Cheol Bae; Dae-Hyun Yoo; Jae-Bum Jun
Journal:  Korean J Intern Med       Date:  2016-03-09       Impact factor: 2.884

8.  Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data.

Authors:  Ruriko Koto; Akihiro Nakajima; Hideki Horiuchi; Hisashi Yamanaka
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-09-16       Impact factor: 2.890

9.  Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan.

Authors:  Ruriko Koto; Akihiro Nakajima; Hideki Horiuchi; Hisashi Yamanaka
Journal:  Ann Rheum Dis       Date:  2021-06-22       Impact factor: 19.103

View more
  1 in total

Review 1.  Genetic Basis of the Epidemiological Features and Clinical Significance of Renal Hypouricemia.

Authors:  Masayuki Hakoda; Kimiyoshi Ichida
Journal:  Biomedicines       Date:  2022-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.